Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
ORIGINAL ARTICLE
Year : 2018  |  Volume : 14  |  Issue : 8  |  Page : 145-151

Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy


1 Department of Oncology, Clinical Medical College in Guangzhou Military General Hospital of Second Military Medical University, Guangzhou 510010, China
2 Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510010, China
3 Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China

Date of Web Publication26-Mar-2018

Correspondence Address:
Wei-Min Zhang
Department of Oncology, General Hospital of Guangzhou Military Command of PLA, No. 111 Liuhua Road, Guangzhou 510010
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.165866

Rights and Permissions

How to cite this article:
Zhou J, Wang D, Zheng JH, Wang Z, Xie B, Zhang WM. Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy. J Can Res Ther 2018;14, Suppl S1:145-51

How to cite this URL:
Zhou J, Wang D, Zheng JH, Wang Z, Xie B, Zhang WM. Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy. J Can Res Ther [serial online] 2018 [cited 2021 Dec 4];14:145-51. Available from: https://www.cancerjournal.net/text.asp?2018/14/8/145/165866

This article has been retracted as per request made by the author, Editor-in-Chief and Editorial Board of the journal.









This article has been cited by
1 Predictive Value of ERCC1 mRNA Level from Receiver-Operator Characteristic and Pretreatment EBV-DNA Virus Load in Stage II Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy with Concurrent Cisplatin
Li Hua, Shaojun Chen, Mengzhuan Wei, Yongqi Shen, Jianxin Long, Zhan Lin, Yiliang Meng, Chengxian Guo, Haixin Huang, Xiaoning Tu, Min Yao
Cancer Biotherapy and Radiopharmaceuticals. 2021;
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article

 Article Access Statistics
    Viewed2569    
    Printed70    
    Emailed0    
    PDF Downloaded140    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]